Results 31 to 40 of about 33,432 (282)

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma

Journal of Diabetes Investigation, 2021
Dopamine receptor agonists are typically used to treat Parkinson’s disease and certain pituitary tumors, such as prolactinoma or a growth hormone‐producing tumor.
Motoyuki Igata, Yoshitaka Yagi, Satoko Hanatani, Masaji Sakaguchi, Norio Ishii, Kayo Yoshinaga, Junji Kawashima, Hiroyuki Motoshima, Eiichi Araki   +8 more
doaj   +1 more source

Peripartum cardiomyopathy: diagnosis and management [PDF]

, 2017
No abstract ...
Coats, Caroline J., Dalzell, Jonathan R., Jackson, Alice M., Jhund, Pardeep S., Petrie, Mark C., Walker, Niki L.   +5 more
core   +1 more source

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses

Frontiers in Veterinary Science, 2022
The objectives of the study were to study the effects of the synthetic ergot alkaloid (EA), bromocriptine, on glucose and lipid metabolism in insulin dysregulated (ID, n = 7) and non-ID (n = 8) mares. Horses were individually housed and fed timothy grass
Caroline M. M. Loos, Kristine L. Urschel, Eric S. Vanzant, Erin L. Oberhaus, Adam D. Bohannan, James L. Klotz, Kyle R. McLeod   +6 more
doaj   +1 more source

The pituitary TGFb1 system as a novel target for the treatment of resistant prolactinomas [PDF]

, 2016
Prolactinomas are the most frequently observed pituitary adenomas and most of themrespond well to conventional treatment with dopamine agonists (DAs).
Camilletti, María Andrea, Diaz, Graciela Susana, Recouvreux, Maria Victoria, Rifkin, Daniel B.   +3 more
core   +2 more sources

Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy [PDF]

, 2016
No abstract ...
Arrigo, Biteker, Blauwet, Brignole, Burkhoff, Cecconi, Duncker, Elkayam, Ersbøll, Fett, Fett, Forster, Gevaert, Haghikia, Haghikia, Haghikia, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Kao, Labbene, Levy, Maisch, Masip, McNamara, Mebazaa, Mebazaa, Miller, Mouquet, Napp, Neumann, O'Connor, Patten, Pillarisetti, Ponikowski, Rasmusson, Regitz-Zagrosek, Schroeter, Seyfarth, Slaughter, Sliwa, Sliwa, Sliwa, Stapel, Strueber, Thiele, Thiele, Tibazarwa   +48 more
core   +8 more sources

Discriminating depression, physical and social anhedonia by neurotransmitter related challenge tests [PDF]

, 2016
The aim of this study was to investigate, if anhedonia, a salient component of depression, shows similar response patterns to neurotransmitter challenge tests as depression, and if the two questionnaire based components Physical (PA) and Social (SA ...
Hennig, Juergen, Netter, Petra
core   +2 more sources

The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO‐HF retrospective cohort study

ESC Heart Failure, 2018
Bromocriptine is thought to facilitate left ventricular (LV) recovery in peripartum cardiomyopathy (PPCM) through inhibition of prolactin secretion. However, this potential therapeutic effect remains controversial and was incompletely studied in diverse ...
M. Tremblay‐Gravel, G. Marquis-Gravel, Robert Avram, O. Desplantie, A. Ducharme, L. Bibas, C. Pacheco, É. Couture, F. Simard, A. Poulin, I. Malhamé, D. Tran, E. Rey, F. Tournoux, L. Harvey, M. Sénéchal, Pierre Bélisle, L. Descarries, P. Farand, N. Pranno, A. Diaz, J. Afilalo, H. Ly, A. Fortier, E. Jolicoeur   +24 more
semanticscholar   +1 more source

Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro [PDF]

, 2001
Angiogenesis, the formation of a new blood supply, is an essential step in tumorigenesis. Although vascular endothelial growth factor (VEGF) is known to be a very potent angiogenic factor in most solid tumors, little is known about its production and ...
Gloddek, Jutta, Hopfner, Ursula, Lohrer, Penny, Losa, Marco, Pagotto, Uberto, Renner, Ulrich, Stalla, Günter K., Uhl, Eberhard   +7 more
core   +1 more source

Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor.

American Journal of Physiology. Endocrinology and Metabolism, 2019
Bromocriptine, a dopamine D2 receptor agonist originally used for the treatment of hyperprolactinemia, is largely successful in reducing hyperglycemia and improving glucose tolerance in type 2 diabetics.
Sarah N. Framnes-DeBoer, Ellen Bakke, Suma Yalamanchili, Hannah Peterson, D. Sandoval, R. Seeley, Deanna M. Arble   +6 more
semanticscholar   +1 more source

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus

Endocrinology, Diabetes & Metabolism, 2020
Objective Sympathetic nervous system (SNS) overactivity is a risk factor for insulin resistance and cardiovascular disease (CVD). We evaluated the impact of bromocriptine‐QR, a dopamine‐agonist antidiabetes medication, on elevated resting heart rate (RHR)
Bindu Chamarthi, Aaron Vinik, Michael Ezrokhi, Anthony H. Cincotta   +3 more
doaj   +1 more source